Alborz Darou honored as Top Exporter of Qazvin Province in 2024

According to the Barekat Health & Pharmaceutical Group, Alborz Darou Company, one of the country’s largest producers of cardiovascular medicines, has been honored as the “Top Exporter of Qazvin Province” in 2024—a recognition that reflects the company’s commitment, expertise, and capabilities in advancing the export of Iranian pharmaceuticals.

At an event organized by the Qazvin Chamber of Commerce, Industries, Mines, and Agriculture, the province’s leading exporters were introduced and celebrated. Out of 22 exemplary exporters, three leading entrepreneurs and 14 active economic journalists were also recognized.

Among the awardees, Alborz Darou was distinguished as one of the pioneering companies in Iran’s pharmaceutical industry.

Key Highlights of Alborz Darou:    

Successful export to more than 10 countries across the Middle East, Central Asia, and Africa

Production and distribution of strategic medicines, including cardiovascular drugs, antibiotics, and injectable formulations

Full compliance with international standards, including GMP requirements

Holding over 3% share of the domestic pharmaceutical market, with a significant role in job creation and foreign currency generation for the country

Future Outlook

In line with the vision and objectives of Barekat Pharmaceutical Group, Alborz Darou aims to evolve into a world-class organization built on agility, innovation, and sustainability, earning the trust of stakeholders and aligning with global industry standards.

With firm determination, the company has set its sights on ranking among the top three pharmaceutical companies in Iran and establishing a strong presence among the leading pharmaceutical players in the Middle East.